Latest news
NextCure reports Q2 2026 net loss $14.9M, cash $20.1M as it pursues merger with Avere - TradingViewTradingView · Thu, 06 Aug 2026 20:35:16 GMTNextCure, Inc. Q2 2026: Net income $(14.9)M, EPS $(2.80) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMTNXTC: Merger with Avere and $320M financing announced as net loss narrows on reduced expenses - TradingViewTradingView · Thu, 06 Aug 2026 20:32:02 GMTNXTC: Merger agreement with Avere Therapeutics drives restructuring, cost cuts, and asset divestitures - TradingViewTradingView · Thu, 06 Aug 2026 20:28:58 GMT